The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Durogesic DTrans 12 micrograms/hour Transdermal Patch

Janssen Sciences Ireland UCPA22612/004/005

Main Information

Trade NameDurogesic DTrans 12 micrograms/hour Transdermal Patch
Active SubstancesFentanyl
Dosage FormTransdermal patch
Licence HolderJanssen Sciences Ireland UC
Licence NumberPA22612/004/005

Group Information

ATC CodeN02AB Phenylpiperidine derivatives
N02AB03 fentanyl


License statusAuthorised
Licence Issued07/07/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back